Long-acting insulin analogue
Insulin Glargine and sun sensitivity (photosensitivity)
Some medications increase the skin's reactivity to ultraviolet light, producing exaggerated sunburn-like rashes after relatively short sun exposure. Insulin Glargine (Insulin Glargine) — used for Insulin glargine is approved as basal insulin therapy in adults and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus when oral or non-insulin injectable th… — falls into the Long-acting insulin analogue class, where photosensitivity prevalence varies by molecule. Below is a focused look at typical photosensitivity patterns with Insulin Glargine at the 100 IU/mL dosing strengths and practical sun-protection steps.
How Insulin Glargine can sensitise the skin to UV
Photosensitivity comes in two main forms: phototoxicity (a direct, sunburn-like reaction occurring within hours of UV exposure, dose-related) and photoallergy (a delayed, eczema-like reaction in a sensitised individual). According to the Insulin Glargine prescribing information, the active ingredient Insulin Glargine may carry a documented or suspected photosensitivity signal; reactions are most common on sun-exposed surfaces — face, V-neck area, dorsal hands, forearms — and tend to be UVA-driven, meaning they can occur even through window glass.
Practical sun-protection guidance during Insulin Glargine
According to general dermatology guidance, people taking Insulin Glargine at the 100 IU/mL doses should apply broad-spectrum sunscreen (SPF 30 or higher, blocking UVA and UVB) on exposed skin, reapply every two hours during outdoor exposure and after swimming or heavy sweating. Wide-brim hats, UPF-rated clothing and sunglasses reduce exposure further. Tanning beds should be avoided. If a photosensitive rash appears, sun exposure should be stopped, the area cooled and the prescriber contacted to discuss the medication.
Frequently asked questions
Does Insulin Glargine cause sunburn more easily? ▾
Whether Insulin Glargine causes increased sunburn risk depends on Insulin Glargine: some medications carry a clear phototoxicity signal in the prescribing information, others do not. People taking Insulin Glargine at the 100 IU/mL dose are advised to monitor exposed skin during the first weeks of treatment and use broad-spectrum sunscreen as a precaution; report any unusual rash on sun-exposed areas to the prescriber.
Should I avoid the sun while on Insulin Glargine? ▾
Total sun avoidance is rarely necessary on Insulin Glargine, but reasonable photoprotection — broad-spectrum SPF 30+, hat, long sleeves at peak UV hours and avoidance of tanning beds — is appropriate for most users. The Insulin Glargine prescribing information indicates whether enhanced precautions are warranted; people with a known phototoxic history or who use multiple photosensitising drugs should follow stricter measures.
Products containing Insulin Glargine
More on Insulin Glargine
- With alcoholInsulin Glargine and alcohol — is it safe to drink?
- With foodShould Insulin Glargine be taken with food?
- Side effectsInsulin Glargine side effects: common, rare and warning signs
- Dosage guideInsulin Glargine dosage guide: how much to take and when
- OnsetHow fast does Insulin Glargine start working?
- DurationHow long does Insulin Glargine last?
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.